REQUEST A DEMO
Total
USD $0.00
Search more companies

Biomin, A.S. (Slovakia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Biomin, A.S. Profile Updated: July 15, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Biomin, A.S. is a company based in Slovakia, with its head office in Cifer. It operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on July 25, 1990. The total number of employees is currently 25 - 49 (2025). The company’s latest financial report indicates a net sales revenue increase of 33.23% in 2025. Its’ total assets recorded a growth of 10.88%. The net profit margin of Biomin, A.S. increased by 8.24% in 2025.

Headquarters
Potocna, 1/1
Cifer; Trnava; Postal Code: 91943

Contact Details: Purchase the Biomin, A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Biomin, A.S. report to view the information.
Registered Capital:
Purchase the Biomin, A.S. report to view the information.
Financial Auditors:
Purchase the Biomin, A.S. report to view the information.
Incorporation Date:
July 25, 1990
Key Executives
Purchase this report to view the information.
Chairman of the Board
Purchase this report to view the information.
Vice-chair of the Board
Purchase this report to view the information.
Member of the Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Company Performance
Financial values in the chart are available after Biomin, A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
33.23%
Total Operating Revenue
23.32%
Operating Profit
301.62%
EBITDA
78.81%
Net Profit/Loss for the Period
365.49%
Total Assets
10.88%
Total Equity
20.15%
Operating Profit Margin
10.2%
Net Profit Margin
8.24%
Return on Equity (ROE)
16.51%
Debt / Equity
-10.8%
Quick Ratio
-0.12%
Cash Ratio
-0.21%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?